quinolones, folic acid antagonists and urinary antiseptics Flashcards
what compound was the structure of fluroquinolones derived from
nalidixic acid
draw structure of nalidixic acid
what is the infection that is most commonly associated with fluoroquinolones
c. difficile and abx resistance
what are the examples of fluoroquinolones
ciprofloxacin, levofloxacin, moxifloxacin, nalidixic acid, norfloxacin, ofloxacin
what is the moa of fluoroquinolones
target primarily DNA gyrase in gram neg bacteria and topoisomerase IV in gram pos bacteria to inhibit DNA replication
do eukaryotic cells (human) contain DNA gyrase
no, have topoisomerase II which works mechanistically similar to DNA gyrase and will be inhibited by fluoroquinolones at high conc
what are the routes for fluoroquinolones
IV, PO, ophthalmic
what is the absorption, distribution and excretion of fluoroquinolones
well absorbed after taking orally, best on empty stomach, to take 2h before or 6h after if ingesting with potential fdi
well distributed in bone, urine (except moxifloxacin), kidney and prostatic tissue
renally cleared for all except moxifloxacin which is hepatically metabolised
what are the indications for ciprofloxacin
gram neg incl penicillin cephalosporin and aminoglycoside resistant strains, only PO agent for pseudomonas, food poisoning caused by enterobacteriae (salmonella, shigella, e coli) and campylobacter, traveller’s diarrhoea caused by e coli, typhoid fever caused by salmonella and anthrax
what conditions of ciprofloxacin not used for
simple uti and MRSA
why is ciprofloxacin not used for MRSA
ineffective against anaerobes and is highly resistant to staphylococcus
what is levofloxacin and mixofloxacin known as
respiratory quinolones
what are the indications of respiratory quinolones
better coverage against gram pos, atypicals and mycobacterium
what are the indications of respiratory quinolones
better coverage against gram pos, atypicals and mycobacterium
what are the adverse effects of fluoroquinolones
- GI
- risk of dysglycemia
- aortic dissections or rupture of aortic aneurysm
- increase risk of c. difficile due to clearing of bowel flora esp with ciprofloxacin
- phototoxicity
- light headedness, dizziness and headache
- joint problems (not for <18yo)
- increase risk of tendonitis or tendon rupture due to systemic use
- peripheral neuropathy (affect tendon, muscle, joints, nerves and can occur any time and last for months or even permanent even after stopping)
- QT prolongation (third gen esp)
can fluoroquinolones be used in pregnancy
category C due to atropathy (fetal cartilage development disorders) and ciprofloxacin detected in breast milk
what are the c/i of fluoroquinolone
myasthenia gravis, muscle weakness, g6pd deficiency
what are the fdi of fluoroquinolone
ingestion with Ca or other divalent or trivalent cations can reduce absorption (Al, Fe, Mg, Zn)
what are the ddi of fluoroquinolone
raise serum level of warfarin and cyclosporin
what is folic acid
vitamin B that helps make RBC
what is the folic acid synthesis pathway
pteridine and PABA -> dihydropteroic acid [dihydropteroate synthease] -> dihydrofolic acid [dihydrofolate synthase] -> tetrahydrofolic acid [dihydrofolate reductase with NADH] -> AA, purine, thymine synthesis
what are the drugs that are anti folate drugs
sulfonamides and trimethoprim
what is the moa of sulfonamides
competitive inhibitor of dihydropteroate synthase enzyme upstream which is the bacterial enzyme that incorporates para-aminobenzoic acid (PABA) into dihydropteroic acid which is the immediate precursor of folic acid
what type of activity does sulfonamides have
bacteriostatic
are mammalian cells affected by the mechanism of sulfonamides
no, we require preformed folic acid (only have step from conversion of dihydrofolic acid into tetrahydrofolic acid)
what is the moa of trimeptoprime
potent inhibitor of dihydrofolate reductase enzyme which inhibits the reduction of dihydrofolic acid into tetrahydrofolic acid which leads to a decreased availability of tetrahydrofolate cofactors required for AA, purine and thymine synthesis which will affect DNA synthesis as a whole
what is the benefit of coadministering sulfonamides and trimeptoprime
introduces sequential blocks in biosynthetic pathway for tetrahydrofolate which allows for synergistic effect
what are the types of sulfonamides and examples of drugs of each type
short acting - sulfisoxazole
intermediate acting - sulfadiazine, sulfamethoxazole
poorly absorbed (active in bowel lumen) - sulfasalazine
topically applied - silver sulfadiazine, sulfacetamide
long acting - sulfadoxine
what are the absorption, distribution, metabolism and excretion characteristics of sulfonamides
absorption: well absorbed after oral administration
distribution: bound to serum albumin and can displace other things bound to serum albumin, distribute throughout bodily fluids and can penetrate into csf even without inflamm, pass placenta barrier and enter fetal tissues
metabolism: acetylation and conjugation occur in liver, byproducts are devoid of antimicrobial activity but has the potential to cause toxicity as it can precipitate in neutral or acidic pH and cause crystaluria which can damage the kidney
excreted by glomerular filtration and secretion, renal dose adjustments needed, may be secreted into breast milk
what are the indications for sulfonamides
pneumocystis (cotrimoxazole), drug resistant malaria and toxoplasmosis (with pyrimethamine), ibs (sulfasalazine), infected burns (topical silver sulfadiazine), STI, respiratory tract infections, acute UTI
what are the indications for sulfonamides
pneumocystis (cotrimoxazole), drug resistant malaria and toxoplasmosis (with pyrimethamine), ibs (sulfasalazine), infected burns (topical silver sulfadiazine), STI, respiratory tract infections, acute UTI
what are the adverse effects of sulfonamides
- crystalluria
- hypersensitivity
- hematopoietic disturbances (hemolytic anemia and thrombocytopenia)
- kernicterus
what is the ddi for sulfonamides
warfarin with sulfamethoxazole
what is the c/i for sulfonamides
newborns, infants <2m, pregnant at term